Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Yuko, Maeda"'
Autor:
Soshiro Ogata, Yuumi Akashi, Satoshi Kato, Yuma Oka, Akari Suda, Shigehito Yoshizaki, Yuko Maeda, Kunihiro Nishimura, Kenji Maeda, Shigeru Nakai
Publikováno v:
Kidney International Reports. 8:584-595
Autor:
Minako Murata, Hideo Yamakawa, Kenji Maeda, Mayuho Maeda, Chiharu Ito, Naohiko Murata, Asami Takeda, Yutaka Nakano, Masaya Washino, Yuko Maeda, Shigeki Takagi, Yasuhiro Otsuka, Hibiki Shinjo
Publikováno v:
Nihon Toseki Igakkai Zasshi. 54:315-324
Autor:
Yuki Shinohara, Mari Matsuoka, Masahiro Ogawa, Ami Tabata, Akiko Hanai, Tara Clinton-McHarg, Yuko Maeda, Masaya Kato, Yuta Sugihara, Momoko Nagai-Tanima, Tadao Tsuboyama, Tomoki Aoyama
Background: Adolescent and young adult (AYA) cancer patients experience complex physical and psychosocial development and diverse lifestyle changes. Therefore, each may have generation-specific needs. This study aimed to develop the Japanese version
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b0e974dc5b22e717347473d306fb6e2
https://doi.org/10.22541/au.165415889.98020605/v1
https://doi.org/10.22541/au.165415889.98020605/v1
Publikováno v:
Journal of Pharmacological Sciences, Vol 118, Iss 4, Pp 543-546 (2012)
We have recently shown that prenatal valproic acid (VPA) exposure causes autism spectrum disorders–like behavioral abnormalities and Nissl-positive cell loss in both prefrontal and somatosensory cortices in male mice. We have also found that VPA-in
Externí odkaz:
https://doaj.org/article/47c953fc10904b5dbc7fa74492126df7
Autor:
Shigeru Nakai, Yuko Maeda, Shigehito Yoshizaki, Takaya Sakusabe, Kunihiro Nishimura, Yuumi Akashi, Kenji Maeda, Soshiro Ogata
Publikováno v:
Kidney international. 101(1)
Multiple 24-hour urine collections are necessary to adequately assess sodium and potassium intake. Here, we assessed kidney function decline for four years after baseline in relation to seven-time averaged 24-hour urinary sodium and potassium excreti
Autor:
Hidenori Arai, Tamio Teramoto, Robert O. Blaustein, Mariko Nakagomi, Katsunori Ikewaki, Hiroyuki Daida, Hirotaka Numaguchi, Masayoshi Shirakawa, Yuichiro Watanabe, Amy O. Johnson-Levonas, Taro Kakikawa, Yuko Maeda
Publikováno v:
Atherosclerosis. 261:69-77
We aimed to assess the effects of cholesteryl ester transfer protein inhibitor anacetrapib added to statin ± other lipid-modifying therapies (LMT) in Japanese patients with dyslipidemia who were not at their LDL-C goal.Patients on a stable dose of s
Autor:
Mariko Nakagomi, Hidenori Arai, Hiroyuki Daida, Masayoshi Shirakawa, Hirotaka Numaguchi, Sanskruti Vaidya, Taro Kakikawa, Yuko Maeda, Amy O. Johnson-Levonas, Tamio Teramoto, Katsunori Ikewaki, Robert O. Blaustein
Publikováno v:
Atherosclerosis. 249:215-223
This multicenter, randomized, double-blind, placebo-controlled study assessed the lipid-modifying efficacy/safety profile of anacetrapib 100 mg added to ongoing statin ± other lipid-modifying therapies (LMT) in Japanese patients with heterozygous fa
Publikováno v:
[Nihon koshu eisei zasshi] Japanese journal of public health. 64(12)
Objectives This study clarified the health status of foreign nationals residing in Japan by comparing their current mortality rates with those of the Japanese population.Methods We focused on foreign national residents and used official statistical d
Autor:
Yuko, Maeda, Noriko, Sato, Makiko, Naka-Mieno, Seijiro, Mori, Tomio, Arai, Masashi, Tanaka, Masaaki, Muramatsu, Motoji, Sawabe
Publikováno v:
Journal of Geriatric Cardiology : JGC
Background Abdominal aortic aneurysm (AAA) is a multifactorial disease with strong genetic components. Various genetic loci have been associated with clinical AAA, but few studies have investigated pathological AAA, an intermediate phenotype of the d
Autor:
Toshio Matsuda, Hitoshi Hashimoto, Erika Takano, Atsuko Hayata-Takano, Yuta Hara, Ryo Watanabe, Takuya Kawanai, Yuko Maeda, Shunsuke Kataoka, Yukio Ago, Kazuhiro Takuma
Publikováno v:
Pharmacology Biochemistry and Behavior. 126:43-49
We recently showed that prenatal exposure to valproic acid (VPA) in mice causes autism-like behavioral abnormalities, including social interaction deficits, anxiety-like behavior and spatial learning disability, in male offspring. In the present stud